1. Home
  2. OCGN vs RR Comparison

OCGN vs RR Comparison

Compare OCGN & RR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • RR
  • Stock Information
  • Founded
  • OCGN 2013
  • RR 2016
  • Country
  • OCGN United States
  • RR United States
  • Employees
  • OCGN N/A
  • RR N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • RR
  • Sector
  • OCGN Health Care
  • RR
  • Exchange
  • OCGN Nasdaq
  • RR Nasdaq
  • Market Cap
  • OCGN 278.3M
  • RR 270.9M
  • IPO Year
  • OCGN N/A
  • RR 2023
  • Fundamental
  • Price
  • OCGN $1.06
  • RR $1.79
  • Analyst Decision
  • OCGN Strong Buy
  • RR Strong Buy
  • Analyst Count
  • OCGN 3
  • RR 1
  • Target Price
  • OCGN $6.00
  • RR $3.50
  • AVG Volume (30 Days)
  • OCGN 6.3M
  • RR 14.1M
  • Earning Date
  • OCGN 08-07-2025
  • RR 08-13-2025
  • Dividend Yield
  • OCGN N/A
  • RR N/A
  • EPS Growth
  • OCGN N/A
  • RR N/A
  • EPS
  • OCGN N/A
  • RR N/A
  • Revenue
  • OCGN $4,522,000.00
  • RR $4,392,000.00
  • Revenue This Year
  • OCGN N/A
  • RR $36.86
  • Revenue Next Year
  • OCGN N/A
  • RR $113.58
  • P/E Ratio
  • OCGN N/A
  • RR N/A
  • Revenue Growth
  • OCGN N/A
  • RR N/A
  • 52 Week Low
  • OCGN $0.52
  • RR $0.30
  • 52 Week High
  • OCGN $1.98
  • RR $5.20
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 59.49
  • RR 39.01
  • Support Level
  • OCGN $1.10
  • RR $1.87
  • Resistance Level
  • OCGN $1.29
  • RR $2.04
  • Average True Range (ATR)
  • OCGN 0.10
  • RR 0.18
  • MACD
  • OCGN -0.00
  • RR -0.07
  • Stochastic Oscillator
  • OCGN 53.06
  • RR 0.00

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a developer of new robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented labor shortages. The company designs, manufacture and sells robots to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company designs its robots to be friendly, customizable to client environments, and extremely reliable.

Share on Social Networks: